Listed

Protalix BioTherapeutics, Inc.

PLXNYSECIK 1006281HealthcareFiscal year ends Dec 31

Reports and events: 399 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Protalix BioTherapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2010-10-2509:35 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950123-10-095509
2010-10-0416:46 ETDEF 14AProxy statementPeriod 2010-11-070000950123-10-091152
2010-09-1310:25 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950123-10-085541
2010-09-0713:27 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-084127
2010-08-3006:19 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-081990
2010-08-1608:00 ET8-K8.01 Other events0000950123-10-077656
2010-08-0516:30 ET10-QQuarterly reportPeriod 2010-06-300000950123-10-073394
2010-07-1310:12 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-065071
2010-07-1208:52 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-064750
2010-06-0808:09 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-056482
2010-05-1816:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-050815
2010-05-1016:30 ET10-QQuarterly reportPeriod 2010-03-310000950123-10-047206
2010-04-2716:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-038864
2010-03-1707:49 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-025421
2010-03-0917:17 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-022638
2010-03-0309:37 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-020348
2010-02-2620:15 ET10-KAnnual reportPeriod 2009-12-310000950123-10-017277
2010-02-1110:51 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-011323
2010-02-0507:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-009028
2010-02-0207:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-007489
2010-01-1416:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-002593
2009-12-2216:30 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0000950123-09-072718
2009-12-1017:33 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-09-069612
2009-12-0107:29 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0000950123-09-067060
2009-11-0916:30 ET10-QQuarterly reportPeriod 2009-09-300000950123-09-060191
2009-10-1515:00 ET8-K/A8.01 Other events; 9.01 Financial statements and exhibits0000950123-09-050607
2009-10-1506:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-09-050478
2009-09-2516:14 ETSC 13D/AOwnership report, active investor, amended0001144204-09-050052
2009-09-2417:10 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-09-045770
2009-09-2410:58 ETSC 13D/AOwnership report, active investor, amended0001178913-09-002261
2009-09-1819:47 ETDEF 14AProxy statementPeriod 2009-11-090000950123-09-043950
2009-09-1416:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-09-042977
2009-09-0816:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-09-041654
2009-08-2616:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-09-038204
2009-08-1716:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-09-035833
2009-08-0317:29 ET10-QQuarterly reportPeriod 2009-06-300000950123-09-029006
2009-07-1410:53 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-09-022058
2009-07-0609:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-09-020137
2009-06-2516:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-09-017282
2009-06-0417:16 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950123-09-011463
2009-06-0216:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950123-09-010496
2009-05-1116:15 ET10-QQuarterly reportPeriod 2009-03-310000950123-09-008534
2009-03-1112:34 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-09-004426
2009-03-0616:51 ET10-Q/AQuarterly report, amendedPeriod 2008-03-310000950123-09-004208
2009-03-0616:22 ET10-Q/AQuarterly report, amendedPeriod 2008-09-300000950123-09-004206
2009-03-0616:22 ET10-Q/AQuarterly report, amendedPeriod 2008-06-300000950123-09-004205
2009-03-0616:06 ET10-KAnnual reportPeriod 2008-12-310000950123-09-004203
2009-02-2617:09 ET8-K4.02 Non-reliance on financial statements0000950123-09-003574
2009-02-1308:16 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950123-09-002694

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.